Lactose-free Infant Formula Market Size, Share & Trends Analysis Report By Product (Organic, Conventional), By Distribution Channel (Supermarkets & Hypermarkets, Convenience Stores, Online), By Region, And Segment Forecasts, 2025 - 2030
Lactose-Free Infant Formula Market Growth & Trends
The global lactose-free infant formula market size is expected to reach USD 33.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% from 2025 to 2030. Growing population of lactose intolerant newborns at the global level is a key factor driving the market.
Increasing working women population is also significantly affecting the market growth. Companies are investing on research and development to increase their focus on lactose-Free Infant Formula product offerings. For instance, Valio Oy has introduced more than 100 lactose free products in 50 countries. In 2016, the company invested around USD 28.0 million on new product development in order to provide high quality assurance to the customers.
The organic category held the largest market share in 2024. The segment growth is attributed to rising demand for premium products in the market. Increasing awareness about the side effects of chemically synthesized products is also driving the consumers to purchase organic products. The conventional category is anticipated to witness significant growth due to its cost effectiveness and availability of the product in the market. The product witnesses majority of its demand from the regions including Asia Pacific and Central and South America.
Supermarkets & hypermarkets segment held the largest revenue share of the global lactose-free infant formula industry in 2024. Availability of a wide product line is a major factor driving the consumers to purchase their products from this channel. The online category is anticipated to emerge as the fastest growing category. Consumers are shifting their preference toward online purchase due to the convenience of doorstep delivery services.
Europe is the largest consumer of lactose-Free Infant Formula. In 2024, the region accounted for 35.0% share of the global revenue. Europeans prefer purchasing these products as they help in preventing diseases like diarrhea among newborns. In Finland, one out of 60,000 newborns are lactose intolerant, which, in turn, is driving the market. Some of the key players operating in the Europe market are GIMME THE GOOD STUFF and Abbott.
The lactose-Free Infant Formula market is competitive in nature due to the presence of many small and large players. Some of the major companies operating in this market are Nestlé; Nutricia; Valio Oy; Abbott; GIMME THE GOOD STUFF; Silverson; Apta Advice; Danone; and Nurture, Inc.
Lactose-Free Infant Formula Market Report Highlights
- Based on products, organic products dominated the global market with a revenue share of 61.9% in 2024.
- On the basis of distribution channel, the supermarkets and hypermarkets segment dominated the global market, accounting for 45.4%% share of the overall revenue in 2024.
- Europe dominated the lactose-Free Infant Formula market in 2024, accounting for 35.0% share of the overall revenue. This trend is projected to continue in the coming years due to growing lactose intolerant population and awareness about the benefits of lactose-Free Infant Formula.
- Various manufacturers are concentrating on lactose free high nutritional infant formulas to meet the existing and future demand of the market.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR’s Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
- Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Lactose-Free Infant Formula Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.2.1. Profit Margin Analysis (Industry-level)
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.3.3. Market Opportunities
- 3.3.4. Market Challenges
- 3.4. Industry Analysis Tools
- 3.4.1. Porter’s Five Forces Analysis
- 3.5. Market Entry Strategies
- Chapter 4. Consumer Behavior Analysis
- 4.1. Demographic Analysis
- 4.2. Consumer Trends and Preferences
- 4.3. Factors Affecting Buying Decision
- 4.4. Consumer Product Adoption
- 4.5. Observations & Recommendations
- Chapter 5. Lactose-Free Infant Formula Market: Product Estimates & Trend Analysis
- 5.1. Lactose-Free Infant Formula Market, By Product: Key Takeaways
- 5.2. Product Movement Analysis & Market Share, 2024 & 2030
- 5.3. Market Estimates & Forecasts, By Product, 2018 - 2030 (USD Million)
- 5.3.1. Organic
- 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. Conventional
- 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 6. Lactose-Free Infant Formula Market: Distribution Channel Estimates & Trend Analysis
- 6.1. Lactose-Free Infant Formula Market, By Distribution Channel: Key Takeaways
- 6.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 6.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
- 6.3.1. Supermarkets & Hypermarkets
- 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2. Convenience Stores
- 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Online
- 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 7. Lactose-Free Infant Formula Market: Regional Estimates & Trend Analysis
- 7.1. Lactose-Free Infant Formula Market: Regional Outlook
- 7.2. Regional Marketplaces: Key Takeaways
- 7.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
- 7.3.1. North America
- 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.1.2. U.S.
- 7.3.1.2.1. Key country dynamics
- 7.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.1.3. Canada
- 7.3.1.3.1. Key country dynamics
- 7.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.1.4. Mexico
- 7.3.1.4.1. Key country dynamics
- 7.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2. Europe
- 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2.2. U.K.
- 7.3.2.2.1. Key country dynamics
- 7.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2.3. Germany
- 7.3.2.3.1. Key country dynamics
- 7.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2.4. France
- 7.3.2.4.1. Key country dynamics
- 7.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.2.5. Italy
- 7.3.2.5.1. Key country dynamics
- 7.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Asia Pacific
- 7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3.2. China
- 7.3.3.2.1. Key country dynamics
- 7.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3.3. India
- 7.3.3.3.1. Key country dynamics
- 7.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3.4. Japan
- 7.3.3.4.1. Key country dynamics
- 7.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3.5. Australia & New Zealand
- 7.3.3.5.1. Key country dynamics
- 7.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Latin America
- 7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4.2. Brazil
- 7.3.4.2.1. Key country dynamics
- 7.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.5. Middle East & Africa
- 7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.5.2. South Africa
- 7.3.5.2.1. Key country dynamics
- 7.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- Chapter 8. Lactose-Free Infant Formula Market: Competitive Analysis
- 8.1. Recent developments & impact analysis, by key market participants
- 8.2. Company Categorization
- 8.3. Participant’s Overview
- 8.4. Financial Performance
- 8.5. Product Benchmarking
- 8.6. Company Market Share Analysis, 2024 (%)
- 8.7. Company Heat Map Analysis
- 8.8. Strategy Mapping
- 8.9. Company Profiles
- 8.9.1. Nestlé
- 8.9.1.1. Company Overview
- 8.9.1.2. Financial Performance
- 8.9.1.3. Product Portfolios
- 8.9.1.4. Strategic Initiatives
- 8.9.2. Nutricia
- 8.9.2.1. Company Overview
- 8.9.2.2. Financial Performance
- 8.9.2.3. Product Portfolios
- 8.9.2.4. Strategic Initiatives
- 8.9.3. Valio Oy
- 8.9.3.1. Company Overview
- 8.9.3.2. Financial Performance
- 8.9.3.3. Product Portfolios
- 8.9.3.4. Strategic Initiatives
- 8.9.4. Abbott
- 8.9.4.1. Company Overview
- 8.9.4.2. Financial Performance
- 8.9.4.3. Product Portfolios
- 8.9.4.4. Strategic Initiatives
- 8.9.5. Gimme the Good Stuff
- 8.9.5.1. Company Overview
- 8.9.5.2. Financial Performance
- 8.9.5.3. Product Portfolios
- 8.9.5.4. Strategic Initiatives
- 8.9.6. Apta Advice
- 8.9.6.1. Company Overview
- 8.9.6.2. Financial Performance
- 8.9.6.3. Product Portfolios
- 8.9.6.4. Strategic Initiatives
- 8.9.7. Danone
- 8.9.7.1. Company Overview
- 8.9.7.2. Financial Performance
- 8.9.7.3. Product Portfolios
- 8.9.7.4. Strategic Initiatives
- 8.9.8. Reckitt Benckiser Group PLC
- 8.9.8.1. Company Overview
- 8.9.8.2. Financial Performance
- 8.9.8.3. Product Portfolios
- 8.9.8.4. Strategic Initiatives
- 8.9.9. Good Start | Dr. Brown's (Perrigo Company)
- 8.9.9.1. Company Overview
- 8.9.9.2. Financial Performance
- 8.9.9.3. Product Portfolios
- 8.9.9.4. Strategic Initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook